Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SVMH

SRIVARU (SVMH) Stock Price, News & Analysis

SRIVARU logo

About SRIVARU Stock (NASDAQ:SVMH)

Key Stats

Today's Range
$0.59
$0.88
50-Day Range
$0.66
$0.66
52-Week Range
$0.59
$12.76
Volume
6.74 million shs
Average Volume
1.90 million shs
Market Capitalization
$5.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SVMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SRIVARU and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SVMH Stock News Headlines

Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
See More Headlines

SVMH Stock Analysis - Frequently Asked Questions

Shares of SRIVARU reverse split before market open on Wednesday, January 15th 2025.The 1-50 reverse split was announced on Monday, January 13th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 14th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that SRIVARU investors own include Meta Platforms (META), COMPASS Pathways (CMPS), CERo Therapeutics (CERO), Banzai International (BNZI), Beneficient (BENF), BigBear.ai (BBAI) and Artelo Biosciences (ARTL).

Company Calendar

Today
10/16/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Motor vehicles & car bodies
Sub-Industry
Automobiles And Trucks
Current Symbol
NASDAQ:SVMH
Previous Symbol
NASDAQ:SVMH
CIK
1973368
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$40 thousand
Price / Sales
142.19
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.14) per share
Price / Book
-4.69

Miscellaneous

Outstanding Shares
8,670,000
Free Float
6,660,000
Market Cap
$5.69 million
Optionable
N/A
Beta
-1.56
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:SVMH) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners